发明名称 NITROGENATED FUSED RING DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USE OF THE SAME FOR MEDICAL PURPOSES
摘要 [PROBLEMS] To provide a compound useful as a prophylactic or therapeutic agent for a sex hormone-dependent disease or the like. [MEANS FOR SOLVING PR OBLEMS] Disclosed are: a nitrogenated fused ring derivative represented by t he general formula (I), or a prodrug, salt or the like thereof, which has a GnRH antagonistic activity; a pharmaceutical composition comprising the deri vative or the prodrug, salt or the like thereof; use of the the derivative o r the prodrug, salt or the like thereof for medical purposes; and others. In the general formula (I), the rings A and B independently represent an aryl or a heteroaryl; RA and RB independently represent a halogen, a cyano, an al kyl, an alkylsulfonyl, -OW1, -SW1, -COW2, -NW3W4, -SO2NW3W4, an aryl or the like; RC represents H or an alkyl; E represents an oxygen atom or the like; U represetns a single bond or an alkylene; and X represents Y, -CO-Y, -SO2-Y , -S-(alkylene)-Y, -O-(alkylene)-Y, -SO2-(alkylene)-Y or the like [wherein Y represents Z, an amino or the like; and Z represents a cycloalkyl, a hetero cycloalkyl, an aryl, a heteroaryl or the like].
申请公布号 CA2680769(A1) 申请公布日期 2008.10.30
申请号 CA20082680769 申请日期 2008.04.16
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 OHNO, KOHSUKE;YONEKUBO, SHIGERU;MIYAGI, TAKASHI;KAMBARA, MIKIE;FUSHIMI, NOBUHIKO
分类号 C07D471/04;A61K31/437;A61K31/52;A61P1/00;A61P5/10;A61P5/24;A61P13/08;A61P15/00;A61P15/08;A61P15/16;A61P15/18;A61P17/00;A61P17/02;A61P17/10;A61P17/14;A61P25/20;A61P25/28;A61P35/00;A61P37/08;A61P43/00;C07D473/00;C07D473/26;C07D473/28;C07D473/30;C07D473/32 主分类号 C07D471/04
代理机构 代理人
主权项
地址